Daniel J. Min

FDA investigator

Appears on 8 documents from 2021 to 2023, mostly at sites in Pennsylvania. Most often cites insanitary conditions (FDCA 501(a)(2)(A)).

8
Documents on file
4.5
Observations per 483
2021
First seen
2023
Most recent

What they cite most

From 36 observations

Activity by year

2021: 1, 2022: 4, 2023: 3

Where

Pennsylvania 4 · New Jersey 3 · Virginia 1

Is Daniel J. Min coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Medical Products Laboratories, Inc.Jul 13, 2023 · Philadelphia, Pennsylvania
483 Bostal LLCApr 5, 2023 · Edison, New Jersey
483 I 3 PHARMACEUTICALS, LLCMar 3, 2023 · Warminster, Pennsylvania
483 Northern VA Compounders PLLCDec 9, 2022 · Sterling, Virginia
483 Mandel l 's Clin i cal PharmacyJun 17, 2022 · Somerset, New Jersey
483 Ferring Production Inc.May 12, 2022 · Parsippany, New Jersey
483 I 3 PHARMACEUTICALS, LLCFeb 22, 2022 · Warminster, Pennsylvania

About this profile

What does Daniel J. Min inspect?

Daniel J. Min appears on 8 documents on file covering 7 sites, mostly in Pennsylvania.

What do they cite most often?

FDCA 501(a)(2)(A) (insanitary conditions), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Daniel J. Min is dated Jul 13, 2023.

FDA Investigator Daniel J. Min: 483s & Inspections · FDA Intel